Hiwacloy Health Center

Hiwacloy Health Center Free Health Services, Consultations & Medicines

3 new cases today.
05/01/2022

3 new cases today.

OMICRON in Bicol
31/12/2021

OMICRON in Bicol

JUST IN‼️
BICOL NAKAPAGTALA NA NG KASO NG COVID-19 OMICRON VARIANT AYON SA DOH
🔴27-anyos na residente ng Bombon , Camarines Sur, recovered, fully vaccinated
🔴46-anyos ng Tigaon , Camarines Sur, recovered, partially vaccinated

PRESS RELEASE MULA SA DOH BICOL:

OMICRON now in Bicol: the public is urged to continue practicing minimum public health standards amid celebration of New Year’s Day
Press Release, December 31, 2021

The Department of Health Bicol Center for Health Development (DOH Bicol CHD) reports cases of the COVID-19 Omicron variant in the Bicol Region. This is the result of a genomic sequencing from the Philippine Genome Center (PGC) received by the Bicol Regional Epidemiology and Surveillance Unit (RESU) today, December 31, 2021.

The first case is a 27 year-old female from Bombon, Camarines Sur. A worker from a private office in Manila, the individual was identified as a close contact of a COVID-19 case. She was tested on December 14, 2021 which yielded a positive result on December 15, 2021. The patient is asymptomatic and fully-vaccinated with Sinovac. The patient has been tagged as recovered.

The second case is a 46 year-old female school staff member in Tigaon, Camarines Sur. The patient was initially positive for Delta and upon repeat test, the result yielded positive for Omicron. She developed mild signs and symptoms on November 16, 2021. On December 6, she was tagged as recovered. The case has no known history of travel abroad or in Manila. The case has been partially vaccinated with Sinovac.

With this development, the Bicol CHD is coordinating with the local health authorities, through the Provincial Epidemiology and Surveillance Unit (PESU) of the Camarines Sur Provincial Health Office for immediate response. An urgent call to trace and identify all contacts up to the 3rd generation of cases is strongly recommended to commence immediately.

The COVID-19 B.1.1.529, or Omicron, was categorized by the World Health Organization as a Variant of Concern due to it having the ability to spread faster than the original COVID-19 strain. Experts from the US Center for Disease Control and Prevention state that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms. Available data shows that available vaccines confer protection against severe illness, hospitalizations, and deaths due to infection with the Omicron variant. However, breakthroughs in people who are fully vaccinated are likely to occur. The Bicol CHD strongly urges the public to strictly maintain and continue practicing the Minimum Public Health Standards, especially during the celebration of New Year’s Day. Properly wearing face masks, sanitizing hands and refraining from attending social gatherings are essential in the prevention of the spread of COVID-19.

Unvaccinated individuals are strongly advised to have themselves inoculated, while those who have received their first dose are advised to receive their second dose to be fully-vaccinated. Booster shots are also highly encouraged. Vaccines remain effective in protecting oneself from severe symptoms and death brought about by COVID-19 and its variants.

With the emergence of the Omicron variant, the Department of Health urges Local Government Units (LGUs) and the general public to heighten case detection and identification of clusters through active case finding, and immediate isolation of suspects and their contacts. LGUs are advised to consider border control and strengthen local response, in particular the implementation of the zoning containment strategy in areas with reported cases. Lastly, it must be emphasized that RT-PCR testing is still the cornerstone for identification of cases.

For those who had 2 doses of SINOVAC.. This may served as your reference for your booster dose 😊
18/11/2021

For those who had 2 doses of SINOVAC..

This may served as your reference for your booster dose 😊

The Effectiveness of one booster dose against COVID 19 for Sinovac vaccine recipients in CHILE

* FINDINGS by the Chile Health Ministry

09/11/2021
09/11/2021

‼️‼️Schedule Reminder::

Ang schedule po for Routine Immunization or bakuna po sa mga babies tig moved po sa November 15, 2021.

Pasensya na po, na reschedule po yan dahil po may mga naka schedule po kami for covid vaccination last this week.

Ang schedule po kang check up kang bados, or Prenatal.. isasabay po sa schedule sa lunes, November 15, 2021 din po pagkaaga.

8am-12pm po yan, sa Hiwacloy Health Center.
Salamat po.. 😊

05/11/2021

Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.

Currently all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it.

Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible, after independent experts recommended halting the company’s study based on the strength of its results. Once Pfizer applies, the FDA could make a decision within weeks or months. If authorized the company would sell the drug under the brand name Paxlovid.

Researchers worldwide have been racing to find a pill against COVID-19 that can be taken at home to ease symptoms, speed recovery and reduce the crushing burden on hospitals and doctors.

Pfizer released preliminary results Friday of its study of 775 adults. Patients who received the company’s drug along with another antiviral shortly after showing COVID-19 symptoms had an 89% reduction in their combined rate of hospitalization or death after a month, compared to patients taking a dummy pill. Fewer than 1% of patients taking the drug needed to be hospitalized and no one died. In the comparison group, 7% were hospitalized and there were seven deaths. | via Associated Press

26/10/2021
26/10/2021

Flu Vaccine is available na po.

For those who are interested to get the Flu vaccine shot, please go to Hiwacloy Health Center for masterlisting of names.

Note:

✅ The Priority Age to get this flu vaccine Shot are the Senior Citizens.,if we have more allocation vaccine, we can vaccinate 18 years old and above.

✅ And take note po, ang priority po aside from seniors , are those fully vaccinated of Covid Vaccines.

Schedule will be posted. Thank you.

21/10/2021
Assessment and Monitoring of Antigen Positive patients.They felt better now, after taking their medications.Hoping for y...
05/10/2021

Assessment and Monitoring of Antigen Positive patients.

They felt better now, after taking their medications.Hoping for your fast recovery po! Buti na lang vaccinated na yung dalawang old age patients.

Vaccine really works!😊

03/10/2021

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.

01/10/2021

Merck & Co Inc's experimental oral drug for COVID-19, molnupiravir, reduced by around 50% the chance of hospitalization or death for patients at risk of severe disease, according to interim clinical trial results announced on Friday.

1 cases in Brgy Hiwacloy
27/09/2021

1 cases in Brgy Hiwacloy

Address

Goa
4422

Website

Alerts

Be the first to know and let us send you an email when Hiwacloy Health Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share